×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
SXTP – 60 degrees pharmaceuticals, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
SXTP
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/28
08:00 am
sxtp
60 Degrees Pharmaceuticals (NASDAQ:SXTP) had its price target lowered by analysts at Ascendiant Capital Markets from $3.00 to $2.80. They now have a "buy" rating on the stock.
Low
Report
60 Degrees Pharmaceuticals (NASDAQ:SXTP) had its price target lowered by analysts at Ascendiant Capital Markets from $3.00 to $2.80. They now have a "buy" rating on the stock.
11/21
08:01 am
sxtp
60 Degrees Pharmaceuticals Announces Clinical Site Now Open for Patient Enrollment for the B-FREE Chronic Babesiosis Study at Mount Sinai Icahn School of Medicine
Low
Report
60 Degrees Pharmaceuticals Announces Clinical Site Now Open for Patient Enrollment for the B-FREE Chronic Babesiosis Study at Mount Sinai Icahn School of Medicine
11/20
06:03 am
sxtp
60 Degrees Pharmaceuticals (NASDAQ:SXTP) was upgraded by analysts at Zacks Research to a "hold" rating.
Neutral
Report
60 Degrees Pharmaceuticals (NASDAQ:SXTP) was upgraded by analysts at Zacks Research to a "hold" rating.
11/14
08:09 am
sxtp
60 Degrees Pharmaceuticals (NASDAQ:SXTP) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
High
Report
60 Degrees Pharmaceuticals (NASDAQ:SXTP) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
11/13
02:09 pm
sxtp
60 Degrees Pharmaceuticals Announces Third Quarter 2025 Results [Yahoo! Finance]
Low
Report
60 Degrees Pharmaceuticals Announces Third Quarter 2025 Results [Yahoo! Finance]
11/13
01:51 pm
sxtp
60 Degrees Pharmaceuticals Announces Third Quarter 2025 Results
Low
Report
60 Degrees Pharmaceuticals Announces Third Quarter 2025 Results
10/15
07:14 am
sxtp
60 Degrees Pharmaceuticals Announces No Detection of Babesia Infection in First Patient Following Treatment with Tafenoquine in Relapsing Babesiosis Study
High
Report
60 Degrees Pharmaceuticals Announces No Detection of Babesia Infection in First Patient Following Treatment with Tafenoquine in Relapsing Babesiosis Study
10/9
07:31 am
sxtp
60 Degrees Pharmaceuticals Unveils Name of Chronic Babesiosis Clinical Trial: B-FREE Chronic Babesiosis Study [Yahoo! Finance]
Low
Report
60 Degrees Pharmaceuticals Unveils Name of Chronic Babesiosis Clinical Trial: B-FREE Chronic Babesiosis Study [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
11/13
01:31 pm
sxtp
Form 10-Q 60 DEGREES PHARMACEUTICA For: Sep 30
Low
Report
Form 10-Q 60 DEGREES PHARMACEUTICA For: Sep 30
11/7
05:31 pm
sxtp
Form SCHEDULE 13G/A 60 DEGREES PHARMACEUTICA Filed by: INTRACOASTAL CAPITAL, LLC
Medium
Report
Form SCHEDULE 13G/A 60 DEGREES PHARMACEUTICA Filed by: INTRACOASTAL CAPITAL, LLC
11/7
04:55 pm
sxtp
Form SCHEDULE 13G/A 60 DEGREES PHARMACEUTICA Filed by: CVI Investments, Inc.
Medium
Report
Form SCHEDULE 13G/A 60 DEGREES PHARMACEUTICA Filed by: CVI Investments, Inc.
10/10
04:15 pm
sxtp
Form 8-K 60 DEGREES PHARMACEUTICA For: Oct 08
Medium
Report
Form 8-K 60 DEGREES PHARMACEUTICA For: Oct 08
9/15
04:38 pm
sxtp
Form 4 60 DEGREES PHARMACEUTICA For: Sep 12 Filed by: DOW GEOFFREY S
Medium
Report
Form 4 60 DEGREES PHARMACEUTICA For: Sep 12 Filed by: DOW GEOFFREY S
9/9
08:01 am
sxtp
Form 8-K 60 DEGREES PHARMACEUTICA For: Sep 09
Low
Report
Form 8-K 60 DEGREES PHARMACEUTICA For: Sep 09
9/5
04:25 pm
sxtp
Form 424B5 60 DEGREES PHARMACEUTICA
Low
Report
Form 424B5 60 DEGREES PHARMACEUTICA
9/5
04:21 pm
sxtp
Form 8-K 60 DEGREES PHARMACEUTICA For: Sep 03
Medium
Report
Form 8-K 60 DEGREES PHARMACEUTICA For: Sep 03
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: